These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8223740)

  • 1. Renal effects of low dose prazosin in patients with congestive heart failure.
    Lang CC; Choy AM; Rahman AR; Struthers AD
    Eur Heart J; 1993 Sep; 14(9):1245-52. PubMed ID: 8223740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin blunts the antinatriuretic effect of circulating angiotensin II in man.
    Lang CC; Rahman AR; Balfour DJ; Struthers AD
    J Hypertens; 1992 Nov; 10(11):1387-95. PubMed ID: 1336524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prazosin on renal function in congestive heart failure.
    Pierpont GL; Franciosa JA; Cohn JN
    Clin Pharmacol Ther; 1980 Sep; 28(3):335-9. PubMed ID: 7408392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man.
    Motwani JG; Struthers AD
    Br J Clin Pharmacol; 1994 Apr; 37(4):355-61. PubMed ID: 8018457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y; Sakurai T; Nakajima H; Kawai C
    Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ibopamine plus prazosin in congestive heart failure.
    Naidoo DP; Rocke A; Mitha AS
    S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
    Bayliss J; Canepa-Anson R; Norell M; Poole-Wilson P; Sutton G
    Eur Heart J; 1986 Oct; 7(10):877-84. PubMed ID: 3539615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of xamoterol in patients with moderate heart failure.
    Bøtker HE; Jensen HK; Krusell LR; Sørensen EV
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):111-6. PubMed ID: 8485065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.